Progress in Medicine: Experts Take Stock
In the year-end editorial, the PLOS Medicine editors ask 11 researchers and clinicians about the most relevant challenges, promising research, and important initiatives in their fields as we head into 2016.
Vyšlo v časopise:
Progress in Medicine: Experts Take Stock. PLoS Med 12(12): e32767. doi:10.1371/journal.pmed.1001933
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001933
Souhrn
In the year-end editorial, the PLOS Medicine editors ask 11 researchers and clinicians about the most relevant challenges, promising research, and important initiatives in their fields as we head into 2016.
Zdroje
1. Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson ANA, et al. Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens. JAMA. 2015 Mar;313(11): 1122. doi: 10.1001/jama.2015.1405 25781441
2. Reed GM. Toward ICD-11: Improving the clinical utility of WHO's International Classification of mental disorders. Professional Psychology: Research and Practice. 2010;41(6): 457–464.
3. Burcu M, Safer DJ, and Zito JM. Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens. Pharmacoepidemiol Drug Saf. 2015 Oct 28. doi: 10.1002/pds.3897
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington, DC: American Psychiatric Association; 2013.
5. Carter SM, Roger W, Heath I, Degeling C, Doust J, Barratt A. The challenge of overdiagnosis begins with its definition. BMJ. 2015;350:h869. doi: 10.1136/bmj.h869 25740625
6. Ahn HS, Welch HG. Korea’s Thyroid Cancer Epidemic: Turning the Tide. N Engl J Med. 2015; 373: 2389–2390. http://dx.doi.org/10.1056/NEJMc1507622 doi: 10.1056/NEJMc1507622 26650173
7. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385: 117–71. doi: 10.1016/S0140-6736(14)61682-2 25530442
8. Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet 2015. Published Online October 21, 2015. doi: http://dx.doi.org/10.1016/S0140-6736(15)00469-9
9. WHO. Global Tuberculosis Report, 2015. WHO: Geneva, 2015. http://www.who.int/tb/publications/global_report/en/ (accessed 18 Nov, 2015).
10. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015; 526: 207–211. doi: 10.1038/nature15535 26375008
11. Hemingway J. Malaria: Fifteen years of interventions. Nature. 2015; 526: 198–199. doi: 10.1038/526198a 26450051
12. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med, 2014; 371: 411–423. doi: 10.1056/NEJMoa1314981 25075834
13. Mita T, Tanabe K. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis. 2012; 65: 465–475. 23183197
14. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015; 15: 415–421. doi: 10.1016/S1473-3099(15)70032-0 25704894
15. Knowler WC1, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6): 393–403. 11832527
16. WHO validates elimination of mother-to-child transmission of HIV and syphilis in Cuba. [Internet]. Geneva: World Health Organization; 2015 [cited 18.11.2015]. http://www.who.int/mediacentre/news/releases/2015/mtct-hiv-cuba/en/
17. Newman L, Kamb M, Hawkes S, Gomez G, Say L, Seuc A, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med. 2013;10(2):e1001396. doi: 10.1371/journal.pmed.1001396 23468598
18. WHO, UNICEF, UNAIDS. Progress report 2011: Global HIV/AIDS response. Epidemic update and health sector progress towards universal access. Geneva: 2011.
19. Kahn JG, Jiwani A, Gomez GB, Hawkes SJ, Chesson HW, Broutet N, et al. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model. PLoS ONE. 2014;9(1):e87510. doi: 10.1371/journal.pone.0087510 24489931
20. World Health Organization. Guidelines. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. September 2015. Geneva: 2015.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2015 Číslo 12
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study
- Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
- Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled
- Police Killings and Police Deaths Are Public Health Data and Can Be Counted